986 filings
Page 3 of 50
4
dy71t3uhagnma2umow
1 Dec 23
SEELOS THERAPEUTICS / Michael Joseph Golembiewski ownership change
4:16pm
4
3tm48
1 Dec 23
SEELOS THERAPEUTICS / Raj Mehra ownership change
4:16pm
8-K
izsdh1mf2hfxm
1 Dec 23
Seelos Therapeutics Announces Closing of Public Offering
4:08pm
8-K
n1bjorlx62v ujzp1
30 Nov 23
Seelos Therapeutics Announces Pricing of $5.55 Million Public Offering
4:59pm
424B5
kxu8y1zs0 la3c9
30 Nov 23
Prospectus supplement for primary offering
4:58pm
424B5
78l 7saqswgshkn8a6r
28 Nov 23
Prospectus supplement for primary offering
4:06pm
424B3
d1a0imsc7okcvnqs
28 Nov 23
Prospectus supplement
4:03pm
8-K
qz9aie4mx 7c
28 Nov 23
Material Modifications to Rights of Security Holders
9:00am
8-K
5dora6ux e6fja
24 Nov 23
Seelos Therapeutics Announces 1-for-30 Reverse Stock Split
12:07pm
8-K
1wq j1zls10qx7s
24 Nov 23
Seelos Therapeutics Announces 1-for-30 Reverse Stock Split
11:10am
8-K
wmttfb
3 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
kv0ksqf9
2 Oct 23
Entry into a Material Definitive Agreement
6:03am
EFFECT
51b8ifm9f1fg 9ibvc
2 Oct 23
Notice of effectiveness
12:15am
424B3
lir0cfr9uuumm7hqnnrj
29 Sep 23
Prospectus supplement
4:56pm
CORRESP
alzo4cs8jol1ho6
26 Sep 23
Correspondence with SEC
12:00am
8-K
xmvx5y ljn
25 Sep 23
Entry into a Material Definitive Agreement
4:06pm
424B5
bjcqieup19sj6k93
25 Sep 23
Prospectus supplement for primary offering
6:02am